Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ICMT | O60725 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4879205 | 1.00 | DPP4 (0.50) | DPP4OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL4879198 | 1.00 | DPP4 (0.50) | DPP4OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL5772883 | 0.90 | OPRM1 (0.44) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL5772880 | 0.90 | OPRM1 (0.44) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL5772887 | 0.90 | OPRM1 (0.44) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4878471 | 0.89 | OPRM1 (0.46) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4878461 | 0.89 | OPRM1 (0.46) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4870930 | 0.86 | MGLL (0.42) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4870923 | 0.86 | MGLL (0.42) | OPRM1OPRD1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4870919 | 0.86 | MGLL (0.42) | OPRM1OPRD1OPRK1OPRL1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080096922-A1 | Novel Sulfonamide derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1736467-A1 | NOVEL SULFONAMIDE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096922-A1 | Novel Sulfonamide derivative | NR4A1, NR4A2, NR4A3 | DPP4 294/4885OPRM1 1290/4885OPRD1 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.